Detalhe da pesquisa
1.
Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial.
J Infect Dis
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527849
2.
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Lancet Infect Dis
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768617
3.
Evaluation of 2 Artificial Intelligence Software for Chest X-Ray Screening and Pulmonary Tuberculosis Diagnosis: Protocol for a Retrospective Case-Control Study.
JMIR Res Protoc
; 12: e36121, 2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490330
4.
Tuberculous pleural effusion in a patient with sympathetic ophthalmia on immunosuppression: a case report.
Trop Dis Travel Med Vaccines
; 7(1): 27, 2021 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649627
5.
Draft Genome Sequences of Local Clinical Isolates of Drug-Resistant and Drug-Sensitive Mycobacterium tuberculosis.
Microbiol Resour Announc
; 10(25): e0035221, 2021 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165334